Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |